For the Inventor, By the Inventor

Enter assignee name

Kirkland, WA, United States of America

Proteotech Inc.

USPTO Granted Patents = 28

% Expired Patents = 92.9

CIPO Patents = 4

EPO Patents = 7

Trademarks = 1

Forward Citations = 52

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Alan D Snow (28 out of 61 patents)

Thomas P Lake (18 out of 25 patents)

Gerardo M Castillo (14 out of 54 patents)

4. Beth P Nguyen (11 out of 15 patents)

5. Virginia J Sanders (10 out of 29 patents)

6. Joel Cummings (9 out of 13 patents)

7. Lesley Larsen (9 out of 12 patents)

8. Qubai Hu (7 out of 12 patents)

9. Judy Cam (6 out of 11 patents)

10. Luke A Esposito (6 out of 7 patents)

11. F Michael Hudson (6 out of 7 patents)

12. Stephen D Lorimer (6 out of 6 patents)

13. David Samuel Larsen (5 out of 11 patents)

14. Rex T Weavers (5 out of 5 patents)

15. Manfred Weigele (4 out of 18 patents)

28 patents: Sort by Forward Citations

1. 9169255 - Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies (2015-10-27),

2. 9133176 - Isolation, purification and synthesis of procyanidin B2 and uses thereof (2015-09-15),

3. 9085549 - Compounds for the treatment of neurodegenerative diseases (2015-07-21),

4. 9051253 - Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's (2015-06-09),

5. 8956818 - Proteoglycan splice variants as therapeutics and diagnostics for amyloid diseases (2015-02-17),

6. 8916598 - Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies (2014-12-23),

7. 8895554 - Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease (2014-11-25),

8. 8865754 - Compounds for the treatment of neurodegenerative diseases (2014-10-21),

9. 8829198 - Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies (2014-09-09),

10. 8754133 - Compounds, compositions and methods for the treatment of inflammatory diseases (2014-06-17),

11. 8592476 - Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies (2013-11-26),

12. 8586585 - Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease (2013-11-19),

13. 8563590 - Compounds, compositions and methods for the treatment of islet amyloid polypeptide (IAPP) accumulation in diabetes (2013-10-22),

14. 8455687 - Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies (2013-06-04),

15. 8227643 - Sirtuin 1 and the treatment of neurodegenerative diseases (2012-07-24),

Proteotech Inc. is a biotechnology company specializing in the development of innovative therapies for neurodegenerative diseases, including Alzheimer's and Parkinson's. With a strong focus on proteomics research, Proteotech aims to identify and target disease-related proteins to create novel treatments. By leveraging cutting-edge technologies and collaborations with academic institutions, Proteotech is dedicated to advancing the field of neurodegenerative disease research and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

28 Patents

#16 in Kirkland, WA

#271 in Washington

#11,997 in US

#23,244 in the World

Kirkland, WA, United States of America

Proteotech Inc.

Forward Citations = 52

27 inventors:

Alan D Snow (28 out of 61 patents)

Thomas P Lake (18 out of 25 patents)

Gerardo M Castillo (14 out of 54 patents)

4. Beth P Nguyen (11 out of 15 patents)

5. Virginia J Sanders (10 out of 29 patents)

Please report any incorrect information to [email protected]

Loading…